EurekAlert! -
17 Mar 2018 06:00
(The Endocrine Society) New scientific evidence has strengthened the case for reserving testosterone therapy for well-documented cases of hypogonadism, a condition where the body does not produce enough testosterone, Endocrine Society experts concluded in an updated Clinical Practice Guideline released today.
Share this Article